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Context:Obesity is associatedwith analtered inflammatory andextracellularmatrix (ECM)profile.
Tenascin C (TNC) is an ECM glycoprotein with proinflammatory effects.
Objective:We aimed to explore the expression levels of TNC in adipose tissue analyzing the con-
tribution of adipocytes and stromovascular fraction cells (SVFC) as well as its impact on inflam-
mation and ECM regulation. We also analyzed the effect of the stimulation with TNF- and lipo-
polysaccharide (LPS) on both SVFC and adipocytes.
Patients andMethods: Samples obtained from75 subjectswere used in the study. Expression levels
of TNC, TLR4,MMP2, andMMP9 were analyzed in visceral adipose tissue (VAT) as well as in both
adipocytes and SVFC. In addition, Tnc expression was measured in two mice models of obesity.
Results:We show, for the first time, that VAT expression levels of TNC are increased in normogly-
cemic and type 2 diabetic obese patients (P 0.01) as well as in obese patients with nonalcoholic
steatohepatitis (P 0.01). Furthermore, expression levels of Tnc in epididymal adipose tissue from
two different mice models of obesity were significantly increased (P  0.01). TNC and TLR4 were
mainly expressed by SVFC, and its expression was significantly enhanced (P  0.01) by TNF-
treatment. LPS treatment also increasedmRNA levels ofTNC.Moreover, theadditionof exogenous
TNC induced (P  0.05) TLR4 and CCL2 mRNA expression in human adipocyte cultures.
Conclusions:These findings indicate thatTNC is involved in theetiopathologyofobesity via visceral
adipose tissue inflammation representinga linkwithECMremodeling. (J Clin EndocrinolMetab97:
E1880–E1889, 2012)
Obesity, characterized by a prolonged positive energybalance, induces different changes in adipose tissue,
including a dramatic alteration of shape and growth of
adipocytes, the differentiation of preadipocytes into adi-
pocytes, and an accumulation of inflammatory cells (1).
These changes are related to the extracellular matrix
(ECM) remodeling (2, 3) and give rise to functional alter-
ations in adipose tissue and variations in its secretion pro-
file of adipokines (4, 5). The degradation of components
of the ECM and regulation of adipose tissue architecture
is mediated by different systems, mainly the matrix met-
alloproteinase (MMP) family and the fibrinolytic plasmin-
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ogen and plasmin system (6). In this sense, the adipose
tissue of obese and insulin-resistant humans shows an in-
crease in components of the ECM, including members of
the collagen family, fibrin, and thrombospondin (7, 8).
Much attention has focused on the adipose tissue
changes inECMand inflammation linked toobesity, high-
lighting the interrelation of both processes in the adipose
transcriptomic signature of obese subjects (9). During the
obesity-associated chronic inflammatory state, the ECM
may act as a scaffold for cell infiltration as well as a res-
ervoir for adipokines and growth factors (10). In addition,
some ECM molecules, a class of the so-called damage-
associated molecular patterns, can also directly activate
the inflammatory process being rapidly released upon tis-
sular damage (11). Tenascin C (TNC) is a large, extracel-
lular matrix glycoprotein that belongs to the damage-as-
sociated molecular patterns family (12). The expression
pattern of TNC is dynamic. Little or no TNC is found in
most healthy adult tissues, being specifically induced and
tightly controlled during acute inflammation and persis-
tently expressed in chronic inflammation (13, 14).TNC is
also reportedly overexpressed in human preadipocytes af-
ter stimulation with secreted factors from activated mac-
rophages (15). Toll-like receptors (TLR) represent a key
molecular link between tissue injury and inflammation
(11, 16). TNC exhibits proinflammatory effects mediated
by the activation of the TLR-4, which in turn promotes
innate and adaptive immune responses, including induc-
tion of proinflammatory cytokines and the matrix metal-
loproteinase family (17). It has been also reported that
TLR4 activation with lipopolysaccharide (LPS) induces
the release of critical proinflammatory cytokines (18) as
well as the expression of procollagen type 1 and integrin
1 (19), suggesting that direct activation of TLR4 has the
potential to induce massive inflammation and may play a
role in ECM remodeling. TNC is frequently coexpressed
with MMP (20), with the inhibition of MMP suppressing
the TNC expression (21).
Recent studies have identified close links between ad-
ipose tissue inflammation and the ECMand expression of
TNC could play a key role (9, 22, 23). To our knowledge,
there are no available data on the expression of TNC in
human visceral (VAT) and sc (SAT) adipose tissue or its
possible involvement in adipose tissue inflammation. The
aimof thepresent studywas todetermine expression levels
ofTNC andTLR4 in adipose tissue aswell and to evaluate
the effect of obesity and the obesity-related comorbidities
type 2 diabetes (T2D) and nonalcoholic fatty liver disease
(NAFLD). Furthermore, we aimed to analyze the expres-
sion levels of TNC in different models of obesity in mice
during active adipose tissue expansion. The role of TNC
in extracellular matrix regulation was also explored by
analyzing its relation with circulating concentrations of
differentMMP aswell as the expression levels ofMMP2
and MMP9. To gain insight into the molecular mecha-
nism involved, the effect of TNF- and LPS on the ex-
pression levels of TNC and TLR4 in cultures of human
adipocytes and stromovascular fraction cells (SVFC)
was further explored. Finally, we also investigated
whether TNC itself can activate the inflammatory re-
sponse in human adipocytes.
Materials and Methods
For detailed Materials and Methods, see Supplemental Data,
published on The Endocrine Society’s Journals Online web site
at http://jcem.endojournals.org.
Patient selection
Adipose tissue samples from 75 subjects (18 males and 57
females) recruited from healthy volunteers and patients attend-
ing the Departments of Endocrinology and Nutrition and Sur-
gery at the Clínica Universidad de Navarra were used. In addi-
tion, an intraoperative liver biopsy was performed in the obese
patients during bariatric surgery to establish a histological di-
agnosis of the hepatic state as well as to analyze TNC gene ex-
pression levels. The samples were collected from patients under-
going either Nissen fundoplication [for hiatus hernia repair in
lean (LN) volunteers] or Roux-en-Y gastric bypass [for morbid
obesity treatment in obese (OB) subjects] at the Clínica Univer-
sidad de Navarra. Tissue samples were immediately frozen in
liquid nitrogen and stored at80C for subsequent analyses. The
studywas approved, fromanethical and scientific standpoint, by
the Hospital’s Ethical Committee responsible for research, and
the written informed consent of participants was obtained.
Blood assays and multiplex studies performed in the study sub-
jects were measured as previously described (4). The transcript
levels for TNC, TLR4, MMP2, and MMP9 were quantified by
real-time PCR (Ref. 24 and Supplemental Table 1) and protein
levels were assessed by Western blot (25).
Cell culture
Human SVFC were isolated from the VAT of obese nor-
moglycemic subjects and differentiated to adipocytes as previ-
ously described (25). Differentiated human visceral adipocytes
and SVFC were serum-starved for 24 h and then treated with
increasing concentrations of TNF- (1, 10, and 100 ng/ml)
(Sigma, St. Louis, MO), LPS (10, 100, and 1000 ng/ml) (Sigma),
and TNC (1, 10, and 100 nmol/liter) (R&D Systems, Minneap-
olis, MN) for 24 h.
Study in animals
In the first animalmodel, 12-wk-oldmaleC57BL/6micewere
maintained during 20wk on a commercial high-fat diet (n 10)
to induce obesity or on a normal diet (n 8) to serve as control.
In the secondmurine model, 10-wk-oldmale wild-type (C57BL/
6J) (n 9) and obese ob/obmice (C57BL/6J) (n 8) were used
to examine the effects in genetically based obesity. Both diets
were isoproteic and contained a similar amount of sodium and
phytates (26). Body weight was recorded on a regular basis to
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monitor progression of the diet-induced and genetically obese
mice. The epididymal adipose tissue depot was carefully dis-
sected out, frozen in liquid nitrogen, and stored at 80 C. All
experimental procedures conformed to the EuropeanGuidelines
for the Care and Use of Laboratory Animals (directive 86/609),
and the studywasapprovedby theEthicalCommittee forAnimal
Experimentation of the University of Navarra.
Statistical analysis
Data are presented as mean  SD. Differences in the propor-
tion of subjects within groups regarding gender were assessed by
using a contingency test (2 test). Differences between groups
wereassessedbyone-wayANOVAfollowedbyTukey’sposthoc
tests, two-tailed unpaired Student’s t test, andMann-WhitneyU
pairwise comparisons as appropriate. Differences between
groups adjusted for agewere analyzed by analysis of covariance.
Pearson’s correlation coefficients (r) were used to analyze the
association between variables.
Results
Expression of TNC in adipose tissue is increased in
obesity and obesity-associated T2D
The biochemical and hormonal characteristics of the
subjects included in the study are shown in Table 1. No
differences in gender distribution between groups was
found (P  0.150). In light of the divergent pathological
consequences of adipose tissue distribution, we assessed
first the gene expression levels ofTNC andTLR4 in paired
samples of VAT and SAT. The mRNA levels of TNC in
TABLE 1. Anthropometric and biochemical characteristics of subjects included in the study
Lean Obese NG Obese T2D
n (male, female) 13 (5, 8) 32 (7, 25) 30 (6, 24)
Age (yr) 36  13 38  14 42  12
BMI (kg/m2) 22.1  3.0 42.2  4.3a 45.6  7.4a
BF (%) 22.4  7.2 52.8  4.8a 52.2  7.2a
Waist (cm) 75.3  9.7 120.3  12.8a 127.8  12.9a,b
Waist to hip ratio 0.80  0.07 0.93  0.09a 0.96  0.08a
SBP (mm Hg) 105  6 121  16a 134  15a,c
DBP (mm Hg) 66  7 75  7a 84  8a,c
Fasting glucose (mg/dl) 87.8  14.8 89.6  10.9 125.4  27.0a,c
2 h OGTT glucose (mg/dl) 114.4  15.4 184.5  45.4
Fasting insulin (U/ml) 6.8  2.9 17.2  16.3 20.2  11.7d
2-h OGTT insulin (U/ml) 88.1  51.1 147.2  85.0
HOMA 1.5  0.8 3.9  2.8 5.6  3.1a
QUICKI 0.371  0.037 0.329  0.038a 0.306  0.024a,b
Triglycerides (mg/dl) 67  25 96  38 139  68a,c
Cholesterol (mg/dl) 176  24 188  41 196  37
LDL-cholesterol (mg/dl) 103  25 115  32 118  32
HDL-cholesterol (mg/dl) 64  12 53  18 47  12d
Leptin (ng/ml) 8.1  4.5 56.6  20.9a 48.2  27.2a
Uric acid (mg/dl) 4.2  0.7 5.7  1.1a 5.5  1.2a
Creatinine (mg/dl) 0.80  0.06 0.80  0.13 0.76  0.14
CRP (mg/liter) 1.0  0.7 9.9  6.7a 7.3  5.1d
Fibrinogen (mg/dl) 215  68 398  72a 349  87a
von Willebrand factor (%) 56  25 131  58a 131  49a
Homocysteine (mol/liter) 6.8  1.5 9.2  2.7d 9.6  2.6a
AST (UI/liter) 13  4 17  13 15  6
ALT (UI/liter) 10  7 22  15d 24  12a
ALP (UI/liter) 93  30 96  26 93  30
-GT (UI/liter) 11  6 20  11 29  17d
MMP-1 (pg/ml) 153.1  102.7 241.9  189.2 213.5  115.5
MMP-2 (ng/ml) 21.84  6.19 19.56  6.36 19.89  5.25
MMP-7 (ng/ml) 2.78  1.53 3.36  2.27 4.06  1.72d
MMP-9 (ng/ml) 0.22  0.05 3.31  0.07a 2.27  0.04a
MMP-10 (pg/ml) 371.3  199.2 218.4  176.5 236.3  106.72
Data are mean  SD. Differences between groups were analyzed by one-way ANOVA followed by Tukey’s post hoc tests. MMP levels
were logarithmically transformed for statistical analysis due to their non-normal distribution. ALP, Alkaline phosphatase; ALT,
alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; DBP, diastolic blood pressure; HOMA,
homeostatic model assessment; OGTT, oral glucose tolerance test; SBP, systolic blood pressure.
a P  0.01 vs. lean.
b P  0.05 vs. obese NG.
c P  0.01 vs. obese NG.
d P  0.05 vs. lean.
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VAT were significantly increased (P  0.004) compared
with SAT,whereas no differences in gene expression levels
of TLR4 were found (Fig. 1, A and B).
Obesity and T2Dwere associatedwith an increased gene
expressionofTNC (P0.001)andTLR4 (P0.05) inVAT
(Fig. 1, C andD). TNC protein expression in the visceral fat
depot exhibited a similar pattern to that observed in the gene
expression analysis (Supplemental Fig. 1A). No changes in
TNC and TLR4 transcript levels were observed in SAT, al-
though a tendency toward an increase in gene expression
levels of TNC was shown (Fig. 1, E and F).
Although no differences between groups were detected
regarding age, because the obese T2D group was on av-
erage slightly older, an analysis of covariance with age as
covariable was performed to investigate the potential bias
of age onmRNA levels ofTNC andTLR4 inVAT. Similar
results were obtained, with TNC and TLR4 expression
being significantly increased (P 0.01)
in bothobese normoglycemic (NG) and
T2D patients compared with lean sub-
jects. In this regard, mRNATNC levels
were positively associated (P  0.05)
with body mass index (BMI) and body
fat (BF) as well as with fasting insulin
concentrations and were negatively
correlated with the quantitative insulin
sensitivity check index (QUICKI) and
high-density lipoprotein (HDL)-cho-
lesterol concentrations (Table 2). A
positive association was also found be-
tweenmRNA levels ofTNC andTLR4
in VAT (r 0.26; P 0.033). No sex-
ual dimorphism was found in the gene
expression levels of both adipokines
(P 0.547 for TNC and P 0.296 for
TLR4).
Based on the fact that TNC exhib-
ited the highest gene expression inVAT
and given the relevance of this depot in
obesity-associated metabolic distur-
bances, the experiments thereafterwere
focused on TNC in this location.
Gene expression of Tnc in murine
models of obesity
To corroborate the human findings
regarding TNC and TLR4 and to fur-
ther explore the potential role of both
molecules in the development of obe-
sity, two different murine models of
obesity, diet-inducedobesity andgenet-
ically obese leptin-deficient (ob/ob)
mice, were used (27). After 12 wk on a
high-fat diet, mice exhibited a higher final body weight
than those on a chow diet (P 0.001). The same was true
for ob/obmice compared with their wild-type littermates
(P  0.001). Both murine obesity models also exhibited
significantly increased epididymal fat depot weights (P
0.01). Tnc and Tlr4 expression was increased (P  0.05)
in the epididymal adipose tissue of both obesity models
compared with those on a chow diet and with wild-type
littermates, respectively (Supplemental Fig. 2).
TNC in adipose tissue in relation to extracellular
matrix regulation and inflammation
Obese subjects with T2D exhibited higher circulating
levels of MMP-7 (P 0.05) andMMP-9 (P 0.01) with
the latter being also increased (P  0.01) in obese NG
patients (P 0.01) comparedwith lean subjects (Table 1).
FIG. 1. Impact of obesity and obesity-associated T2D on gene expression levels of TNC and TLR4
in adipose tissue. A and B, Analysis of mRNA levels of TNC and TLR4 in VAT and SAT (VAT: n
75; SAT: n 23). Bars represent the mean SD of the ratio between the gene expression to 18S
rRNA. Differences between groups were analyzed by a two-tailed unpaired Student’s t test. C and
D, Gene expression levels of TNC and TRL4 in VAT of LN, obese NG, and obese T2D volunteers
(LN: n 13; OB-NG: n 32; OB-T2D: n 30). E and F, Gene expression levels of TNC and TRL4
in SAT of LN, obese NG, and obese T2D volunteers (LN: n 7; OB-NG: n 7; OB-T2D: n 9).
Bars represent the mean SD of the ratio between the gene expression to 18S rRNA. The
expression level in LN subjects was assumed to be 1. Differences between groups were analyzed
by one-way ANOVA followed by Tukey’s tests. *, P 0.05, **, P 0.01 vs. LN.
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Moreover, MMP-9 mRNA expression levels were signif-
icantly higher (P  0.001) in both obese NG and obese
with T2D subjects compared with lean volunteers. Gene
expression levels of MMP2 followed a similar trend, al-
though no statistically significant differences were de-
tected (Supplemental Fig. 3). A positive correlation be-
tween the circulating concentrations and the expression
levels in VAT of MMP-9 (r  0.32; P  0.022) was ob-
served. Moreover, gene expression levels of TNC in VAT
were positively correlated with the extracellular matrix
regulatory genesMMP9 (P 0.01) andMMP2 (P 0.01)
(Table 2).
We next investigated whether TNC can activate the
expression of TLR4 and genes involved in the inflamma-
tory response in human adipocytes. Cells were stimulated
with increasing concentrations ofTNC for 24h.As shown
inFig. 2,TNCtreatment significantly enhanced (P0.05)
the mRNA levels of TLR4 and CCL2 in adipocytes,
whereas a slight increase of gene expression levels of
TNFA was observed. We also detected an increased gene
expression of CD68 andMMP9 after TNC treatment al-
though the differences were not statistically significant.
Effect of inflammatory factors on mRNA levels of
TNC and TLR4 in human adipocytes and SVFC
Because VAT of obese patients exhibited an increased
macrophage infiltration (especially in those individuals
with a high BMI), to identify which cell type preferentially
contributed to the elevated TNC and TLR4 levels ob-
served, adipocytes and SVFC were isolated from VAT
samples obtained from 15 morbidly obese patients. Al-
though both TNC and TLR4 expression were readily ev-
ident in mature adipocytes, gene expression levels were
mainly detected in the SVFC (P 0.01) (Fig. 3, A and B).
Furthermore, the presence of TNC in sections of visceral
adipose tissue was confirmed by immunohistochemistry
(Supplemental Fig. 1B). Both adipocytes and SVFC were
immunopositive for TNC, although a marked staining in
SVFC was observed.
Based on the fact that TNF- is linked to the inflam-
matory response in obesity being a well-known regulator
of the production of certain adipokines, the effect of
TNF- on TNC and TLR4 expression in human visceral
adipocytes and SVFC was examined. Cells were stimu-
latedwith increasing concentrations ofTNF- for 24h.As
shown in Fig. 3, C and E, TNF- treatment significantly
enhanced the mRNA levels of TNC in both SVFC and
adipocytes. Although we also detected an increased gene
expression of TLR4 after TNF- treatment in adipocytes
(P  0.05), the stimulation was not dose dependent, and
thehuge variation foundbetween samplesmade it difficult
to conclude that TNF- stimulates TLR4 expression. No
statistically significant differenceswere found for the tran-
script levels of TLR4 in SVFC (Fig. 3, D and F).
Because bacterial LPS initiates acute inflammatory re-
sponses typical of the host reaction to tissue injury or in-
fection, we also analyzed the effect of LPS on human vis-
ceral adipocytes. Gene expression levels of TNC were
strongly induced by LPS (P  0.001), whereas gene ex-
pression of TLR4 was increased, but the differences felt
out of statistical significance (Fig. 3, G and H).
Increased expression of TNC in VAT is related to
NAFLD
Because one of the best known hepatic derangements
associated to obesity and diabetes is NAFLD,we aimed to
investigate the regulation of TNC and TLR4 as well as
MMP2 andMMP9 in this condition. Obese patients were
classified according to the presence or absence of NAFLD
andwere matched by age and BMI to exclude the effect of
obesity in gene expression levels (Supplemental Table 2).
Circulating concentrations of the hepatic enzyme -glu-
tamyltransferase (-GT) (P  0.05) were increased in
NAFLD patients, who also showed elevated circulating
concentrations of glucose 2 h after an oral glucose toler-
ance test and triglycerides (P0.05).Real-timePCRanal-
ysis indicated that mRNA expression levels of TNC and
TLR4 as well as those of bothMMP in VAT were signif-
icantly higher (P 0.05) in patients withNAFLD (Fig. 4).
The gene expression levels of TNC were also assessed in
hepatic biopsies in a subgroup of obese subjects, being
higher in obese patients with T2D, although no statisti-
cally significant differences were reached (Supplemental
Fig. 4A). We also explored the effect of NAFLD on TNC
mRNAexpression in the liver, and no differences between
the groups were found (Supplemental Fig. 4B).
TABLE 2. Univariate analysis of the correlation
between mRNA expression levels of TNC and TLR4 in
VAT with anthropometic and metabolic variables as well
as with genes involved in extracellular matrix regulation
TNC mRNA
expression
TLR4 mRNA
expression
r P r P
TNC mRNA expression — — 0.26 0.033
TLR4 mRNA expression 0.26 0.033 — —
MMP2 mRNA expression 0.35 0.003 0.45 <0.001
MMP9 mRNA expression 0.38 <0.001 0.35 0.003
BMI 0.37 0.002 0.31 0.012
BF 0.26 0.038 0.22 0.085
QUICKI 0.33 0.011 0.04 0.791
HDL-cholesterol 0.32 0.016 0.06 0.651
Bold values denote statistically significant P values. —, The correlation
of the TNC gene levels or TLR4 gene expression with itself is not
performed/provided.
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Discussion
Adipose tissue is a complex organ that regulates and co-
ordinates metabolic homeostatic mechanisms. With the
development of obesity, adipose tissue expands and ex-
hibits an enhanced systemic low-grade inflammation pro-
file involving macrophage infiltration together with an
active adipokineproductionand releasebyadipocytes and
other surrounding cells (2). To accommodate the changes,
ECM remodeling takes place via the degradation of the
existing and the production of new ECM components.
The ECM is crucial for adipocyte development and func-
tion, thereby playing an important role in weight regula-
tion, obesity and lipid metabolism (5).
A tight association between the ECM protein TNC and
early inflammatory responseshasbeendescribed (10).How-
ever, the clinical implications of TNC in obesity and adipose
tissue remodeling remain largely unknown. Our findings
provide evidence, for the first time, that TNC levels are in-
creased in obese subjects in comparisonwith lean volunteers
as well as in VAT compared with SAT.
Consistently, we further show that the
adipose tissue gene expression levels of
Tnc are also increased in two murine
models of obesity representative of the
genetically based and exogenously in-
duced disease.We also demonstrate that
the increasedtranscript levelsofTNCob-
served in obesity are further aggravated
in the presence of NAFLD.Of interest, a
correlation between gene expression lev-
els of TNC and TLR4 as well asMMP2
andMMP9 in VAT was found. Finally,
we show that the proinflammatory cyto-
kine TNF- elevates the mRNA levels of
TNC in cultures of human visceral adi-
pocytes and SVFC.
VATand SATdisplay differentmor-
phological and functional featureswith
the increased visceral adiposity being
responsible of themetabolic abnormal-
ities related toobesity (28).Our study is
the first to show that obese patients ex-
hibit an 8-fold increase in gene expres-
sion levels of TNC in VAT compared
with lean individuals, whereas no dif-
ferences are evident in SAT. The signif-
icant positive correlation found be-
tweenTNC levels and BF indicates that
TNC is related to the adipose tissue
amount. Interestingly, the expression
ofTNC is highly regulated and shows a
highly circumscribed pattern of expres-
sion to areas of active tissue reorganization and inflam-
mation, suggesting a link between an increase of ECM
remodeling in VAT and its inflammatory profile (15). In
addition to cellular adhesion receptors, cells also express
receptors for ECM proteins, such as TLR, whose activa-
tion lead to the up-regulation of intracellular signaling
pathways resulting in the production of inflammatory cy-
tokines. In this regard, we detected higher expression lev-
els of TLR4 in both obese groups compared with lean
volunteers as well as a positive association with the TNC
expression levels. Recently it has been identified that the
activation of TLR4 through TNC is required for main-
taining joint inflammation but not for the initiation of
inflammation (17). Moreover, Tnc-knockout mice have
been showntobeprotected fromsustainedanderosive joint
inflammation. Induction of TNC is highly associated with a
wide range of diseases related to inflammation, including
diabetes, atherosclerosis, ulcerative colitis, inflammatory
boweldisease,vasculitis,or lung inflammation(29).Anearly
FIG. 2. Gene expression levels of TLR4 (A), chemokine (C-C motif) ligand 2 (CCL2) (B), TNFA
(C), CD68 antigen (CD68) (D), and MMP9 (E) in human visceral adipocytes stimulated with
recombinant TNC (1.0–100 nmol/liter) for 24 h. Gene expression levels in the unstimulated
cells were assumed to be 1. Values are the mean  SD (n  6 per group). Differences
between groups were analyzed by one-way ANOVA followed by Tukey’s tests. *, P  0.05
and **, P  0.01 vs. unstimulated cells.
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inflammatory response is generally associated with en-
hanced TNC levels both in plasma and tissue (13). In this
sense, plasma levels of TNC constitute a well-known indi-
cator for inflammatoryboweldisease, chronichepatitisC,or
myocardial infarction(30,31). Itwouldbevery interestingto
evaluate circulating levels ofTNCin lightof its physiological
consequences. The study of circulating
levels of TNC may help to better under-
stand the role of TNC in obesity and its
associated comorbidities.
The higher expression levels of TNC
andTLR4 in the SVFC of visceral fat tis-
sue compared with adipocytes, observed
in the present study indicate that diffe-
rent cell types such as mononuclear cells
(monocytes, macrophages, and lympho-
cytes) among others, may produce this
glycoprotein. Noteworthy, SVFC repre-
sent a source of inflammation-related
molecules that exert a local action on ad-
ipose tissue biology, particularly within
theenlargedadiposemass. Ithasbeende-
scribed that macrophages that accumu-
latewithin theenlargedadipose tissueac-
quire particular remodeling phenotypes,
releasing MMP and/or stimulating the
expression of inflammatory genes in hu-
man adipocytes (32, 33). In this context,
the obese patients included in the study
showed increased circulating levels of
MMP-7andMMP-9.Furthermore, previ-
ous studies have demonstrated that mac-
rophage-secreted factors induce overex-
pression of ECM genes in inflammatory
preadipocytes increasing the deposition of
TNC (15). In this sense, we have shown
increased gene expression levels ofMMP9
in VAT from obese patients accompanied
by a clear positive association between
mRNA levels of TNC with MMP9 and
MMP2,whichis in linewithpreviousstud-
ies reporting thatTNCis cleavedbyMMP
(34, 35). Reciprocally, TNC increases
MMP9 expression (36) and regulates
vascular endothelial growth factor (37),
highlighting a role in the control of angio-
genesis. Recent studies have shown an al-
teration in the expression or activity of
MMP in obesity underscoring their in-
volvement in the pathophysiology of obe-
sity-associated comorbidities (34).
To corroborate the human findings
and to further explore the potential role of TNC in the
development of obesity, gene expression levels of this pro-
tein were analyzed in twomicemodels of obesity differing
in their underlying cause, namely genetic as opposed to
diet-induced obesity. Increased expression levels ofTnc in
epidydimal fat pads were observed in both experimental
FIG. 3. Gene expression levels of TNC and TLR4 in human visceral adipocytes and SVFC. A and B,
Comparison of TNC and TLR4 gene expression in adipocytes and SVFC isolated from VAT of obese
patients. Bars represent the mean SD of the ratio between the gene expression to 18S rRNA.
The expression level in adipocytes was assumed to be 1 (adipocytes: n 9; SVFC: n 11).
Statistical differences were assessed by a two-tailed unpaired Student’s t test. *, P 0.05, **, P
0.01 vs. adipocytes. C and D, Effect of TNF-. Bar graphs show the effect of TNF- incubated for
24 h on the transcript levels of TNC and TLR4 in visceral SVFC. E and F, Transcript levels of TNC
and TLR4 after 24 h incubation with TNF- in visceral adipocytes. G and H, Gene expression levels
of TNC and TLR4 in human visceral adipocytes after LPS treatment. The gene expression levels in
the unstimulated cells were assumed to be 1. Values are the mean SD (n 6 per group).
Differences between groups were analyzed by one-way ANOVA followed by Tukey’s tests. CTL,
Control. *, P 0.05; ***, P 0.01 vs. unstimulated cells.
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models of obesity. This is in agreementwith previous stud-
ies describing that a high-fat diet increases the expression
of procollagens and microfibril-forming components in
gonadal adipose tissue, thereby pointing to an enhanced
matrix turnover induced by high-fat feeding (38). It has
been also described that n-3 polyunsaturated fatty acids
(PUFA) inhibited the high-fat diet-induced up-regulation
of genes involved in matrix remodeling and restored the
adipocyte enlargement in adipose tissue of obese diabetic
mice (38). Moreover, n-3 PUFA prevented adipose tissue
inflammation induced by high-fat diet in obese diabetic
mice, thereby suggesting that beneficial effects of n-3
PUFAondiabetes development could bemediatedby their
effect on adipose tissue inflammation (39). Furthermore,
in the genetically obese ob/obmice due to the lack of func-
tional leptin, increased adipose tissue expression levels of
Tnc have been also detected. In this regard, epidydimal
adipose tissue of genetically obese db/db mice reportedly
exhibit an overexpression of collagens with collagen VI-
null ob/ob mice showing a decrease of inflammatory
markers in adipose tissue (40).
Our in vitro studies provide, to our knowledge, the first
evidence of an induction of the TNC expression levels in
human visceral adipocytes and SVFCupon stimulationwith
the proinflammatory cytokine TNF-. Although TGF-1
was the first growth factor reported to up-regulate the
mRNAofTNC (41),other inflammatoryandgrowthfactors
such as epidermal growth factor or basic fibroblast growth
factor have been shown to increase TNC
production in adipose tissue-derived
stem cells and macrophages (42). Be-
cause TNC is also stimulated by antiin-
flammatory cytokines, it has been sug-
gested that this ECM protein may act as
amechanism to protect tissues during in-
flammation that is required to resolve in-
flammation rather than to trigger it. In
accordance with this hypothesis, TNC
has been shown to alter the adhesion
properties of human monocytes to fi-
bronectin (43).Adipocytesarecapableof
sensing the presence of LPS, a bacterial
cell wall component. Interestingly, LPS
administrationhasbeen shown to induce
systemic inflammation signaling via
TLR-4,without changes in its expression
in3T3-L1adipocytes (44,45). Ithasbeen
also described that in response to stimu-
lation with LPS, human monocytes sig-
nificantly increased the expression of
TNC. We detected for the first time that
LPS induced the expression of TNC in
human visceral adipocytes with the ex-
pression of TLR4 remaining unchanged. Moreover, we
found that TNC stimulated mRNA expression levels of
TLR4 and CCL2 in adipocytes, strengthening the role of
TNC in the inflammatory response of adipose tissue.
Obesity is tightly linked to hepatic alterations, partic-
ularly NAFLD, mainly due to the state of chronic low-
grade systemic inflammation. In this regard, IL-6 concen-
trationshavebeen strongly associatedwith fatty liver (46).
The expression ofTNC detected in adipose tissue of obese
patients was further enhanced by NAFLD. Moreover,
gene expression levels of the remodeling metalloprotei-
nases,MMP2 andMMP9, were increased in the NAFLD
patients. Noteworthy, a sequential increase in the TNC
depositionandexpression in the liver of thewild-typemice
after concanavalinA treatment hasbeen found (47).How-
ever, no differences were found in the TNCmRNA levels
in liver biopsies, suggesting an important role of adipose
TNC in the regulation of inflammation. Interestingly, the
increasing amounts of TNC in rare tumors of Ito cells,
which are fat-storing cells,which represent approximately
20% of the hepatic sinusoidal cells (48), as well as in
chronic hepatitis C (49) have been described. TNCmay be
involved in NAFLD by enhancing the inflammatory re-
sponse or by its actions on ECM synthesis and assembly
during tissue repair (29, 50). Surprisingly, patients with
NAFLD presented normal levels of the hepatic enzymes,
alanine aminotransferase, aspartate aminotransferase,
FIG. 4. Gene expression levels of TNC (A), TLR4 (B), MMP9 (C), and MMP2 (D) in the VAT of
obese patients with and without NAFLD. Bars represent the mean  SD of the ratio between
the gene expression to 18S rRNA. The expression level in non-NAFLD subjects was assumed to
be 1 (non-NAFLD: n  18; NAFLD: n  25). Differences between groups were assessed by
two-tailed unpaired Student’s t test.
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and -GT, which may be due to the relatively low age of
the selected patients because NAFLD worsens with ad-
vanced age (51).
In summary, our findings demonstrate that TNC levels
are increased in VAT of obese subjects with or without
T2D and in obese volunteers with NAFLD. The positive
association with TLR4,MMP2, andMMP9 as well as its
stimulation after TNF- treatment in both adipocytes and
SVFC suggests a role for this protein in maintaining the
chronic inflammatory response associated to obesity,
whichmaybe related to an increase of extracellularmatrix
remodeling.
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